TAPI — the API manufacturing division of Teva Pharmaceuticals — is the world’s number two producer of APIs. The company's CDMO services draw on the nearly 90 years of API development and manufacturing excellence associated with the firm, offering regulatory starting materials (RSMs), intermediates, and APIs across a wide range of modalities. With a strong global presence, deep expertise in advanced technologies, and a commitment to quality and compliance, TAPI offers tailor-made solutions for any stage of development, manufacture, or commercialization.